As previously described, miR-16-5p played a tumor-suppressing effects to slow down cancer progression [19–21], including GC [22–24], which evidenced the opposite effects of LINC00649 and miR-16-5p in regulating GC development. The gene discussed is LINC00649; the disease is cancer.